{"id":12732,"date":"2025-07-22T08:24:08","date_gmt":"2025-07-22T12:24:08","guid":{"rendered":"https:\/\/www.rigicon.com\/glossary-term\/active-monitoring\/"},"modified":"2025-07-22T08:24:08","modified_gmt":"2025-07-22T12:24:08","slug":"monitoramento-ativo","status":"publish","type":"glossary-term","link":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","title":{"rendered":"Monitoramento Ativo"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","glossary-category":[126],"glossary-product":[],"class_list":["post-12732","glossary-term","type-glossary-term","status-publish","hentry","glossary-category-urological-conditions"],"acf":{"gt-definition":"<p>O monitoramento ativo, tamb\u00e9m conhecido como vigil\u00e2ncia ativa, \u00e9 uma estrat\u00e9gia de observar de perto uma condi\u00e7\u00e3o sem tratamento imediato, intervindo apenas se ocorrer progress\u00e3o.<sup>1<\/sup> Essa abordagem envolve monitoramento regular por meio de testes e exames programados para rastrear quaisquer altera\u00e7\u00f5es na condi\u00e7\u00e3o.<sup>2<\/sup> \u00c9 usada principalmente para condi\u00e7\u00f5es de crescimento lento ou que apresentam risco imediato m\u00ednimo, especialmente nos casos em que os efeitos colaterais potenciais do tratamento podem superar os benef\u00edcios do tratamento imediato. interven\u00e7\u00e3o.<sup>3<\/sup> O monitoramento ativo permite que os profissionais de sa\u00fade atrasem ou evitem tratamentos desnecess\u00e1rios, mantendo a capacidade de intervir prontamente se a condi\u00e7\u00e3o piorar.<sup>4<\/sup> Essa abordagem \u00e9 mais comumente implementada no tratamento do c\u00e2ncer de pr\u00f3stata de baixo risco, mas tamb\u00e9m pode ser aplicada a outras condi\u00e7\u00f5es.<sup>5<\/sup><\/p>\n<p>O monitoramento ativo na urologia consiste no acompanhamento regular e estruturado de condi\u00e7\u00f5es que n\u00e3o requerem interven\u00e7\u00e3o imediata, utilizando exames de imagem, laboratoriais e cl\u00ednicos peri\u00f3dicos. Difere da vigil\u00e2ncia ativa (utilizada no c\u00e2ncer de pr\u00f3stata com inten\u00e7\u00e3o curativa diferida) por ser aplicado a condi\u00e7\u00f5es benignas ou de baixo risco, como angiomiolipomas pequenos, cistos renais e c\u00e1lculos assintom\u00e1ticos.<\/p>","gt-synonyms":"Vigil\u00e2ncia ativa, espera vigilante, manejo expectante, observa\u00e7\u00e3o, protocolo de vigil\u00e2ncia, protocolo de monitoramento, tratamento diferido","gt-citation":"[1] Cooperberg MR, Meeks W, Fang R, Gaylis FD, Catalona WJ, Makarov DV. Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US. JAMA Netw Open. 2023;6(3):e231439. DOI: 10.1001\/jamanetworkopen.2023.1439\n\n[2] National Cancer Institute. Definition of active surveillance. Cancer.gov. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/active-surveillance. Accessed June 2, 2025.\n\n[3] Mayo Clinic. Active surveillance for prostate cancer. https:\/\/www.mayoclinic.org\/tests-procedures\/active-surveillance-for-prostate-cancer\/about\/pac-20384946. Updated November 15, 2023. Accessed June 2, 2025.\n\n[4] American Cancer Society. Observation or Active Surveillance for Prostate Cancer. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/treating\/watchful-waiting.html. Updated November 22, 2023. Accessed June 2, 2025.\n\n[5] Moore CM, Giganti F, Albertsen P, et al. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer: A Consensus Statement from the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative. Eur Urol Oncol. 2023;6(2):155-165. DOI: 10.1016\/j.euo.2023.01.001","gt-clinical-context":"<p>O monitoramento ativo \u00e9 utilizado principalmente em ambientes cl\u00ednicos onde a interven\u00e7\u00e3o imediata pode n\u00e3o ser necess\u00e1ria ou ben\u00e9fica.<sup>1<\/sup> A aplica\u00e7\u00e3o mais comum \u00e9 no tratamento do c\u00e2ncer de pr\u00f3stata de baixo risco, onde se tornou a abordagem preferida de acordo com as principais diretrizes cl\u00ednicas.<sup>2<\/sup> Essa estrat\u00e9gia \u00e9 particularmente apropriada para pacientes com tumores pequenos, de crescimento lento, confinados a uma \u00e1rea espec\u00edfica e que n\u00e3o causam sintomas.<sup>3<\/sup><\/p>\n\n<p>Os crit\u00e9rios de sele\u00e7\u00e3o de pacientes para monitoramento ativo normalmente incluem:<\/p>\n<ul>\n <li>Classifica\u00e7\u00e3o de doen\u00e7a de baixo risco (por exemplo, baixo escore de Gleason no c\u00e2ncer de pr\u00f3stata)<sup>4<\/sup><\/li>\n <li>Extens\u00e3o limitada da doen\u00e7a (por exemplo, confinada a uma \u00e1rea)<sup>3<\/sup><\/li>\n <li>Aus\u00eancia de sintomas relacionados \u00e0 doen\u00e7a<sup>3<\/sup><\/li>\n <li>Considera\u00e7\u00e3o da idade do paciente e comorbidades que podem limitar a expectativa de vida<sup>4<\/sup><\/li><\/ul>\n\n<p>O protocolo de monitoramento geralmente envolve:<\/p>\n<ul>\n <li>Consultas m\u00e9dicas regulares (normalmente a cada 3-6 meses)<sup>4<\/sup><\/li>\n <li>Exames de sangue peri\u00f3dicos (por exemplo, testes de PSA no c\u00e2ncer de pr\u00f3stata)<sup>4<\/sup><\/li>\n <li>Estudos de imagem em intervalos definidos (por exemplo, resson\u00e2ncia magn\u00e9tica)<sup>5<\/sup><\/li>\n <li>Repetir bi\u00f3psias quando indicado por altera\u00e7\u00f5es em outros par\u00e2metros<sup>5<\/sup><\/li><\/ul>\n\n<p>Os resultados esperados com monitoramento ativo incluem:<\/p>\n<ul>\n <li>Evitar efeitos colaterais desnecess\u00e1rios do tratamento para muitos pacientes<sup>4<\/sup><\/li>\n <li>Preserva\u00e7\u00e3o da qualidade de vida durante o per\u00edodo de monitoramento<sup>4<\/sup><\/li>\n <li>Nenhum impacto significativo na sobrevida espec\u00edfica do c\u00e2ncer para pacientes adequadamente selecionados<sup>5<\/sup><\/li>\n <li>Potencial para interven\u00e7\u00e3o tardia se a progress\u00e3o for detectada<sup>5<\/sup><\/li><\/ul>\n\n<p>A decis\u00e3o de fazer a transi\u00e7\u00e3o do monitoramento ativo para o tratamento ativo \u00e9 normalmente baseada em evid\u00eancias de progress\u00e3o da doen\u00e7a, como aumento dos n\u00edveis de biomarcadores, altera\u00e7\u00f5es nos achados de imagem ou piora dos sintomas.<sup>5<\/sup><\/p>\n<p>O protocolo de monitoramento varia conforme a condi\u00e7\u00e3o: angiomiolipomas < 4 cm com ultrassonografia anual, cistos renais Bosniak II com TC peri\u00f3dica, c\u00e1lculos renais assintom\u00e1ticos < 5 mm com controle de imagem semestral. A EAU enfatiza que o monitoramento deve ser individualizado, considerando fatores como crescimento da les\u00e3o, sintomas e prefer\u00eancia do paciente. A transi\u00e7\u00e3o para tratamento ativo \u00e9 indicada quando crit\u00e9rios pr\u00e9-definidos s\u00e3o atingidos.<\/p>","gt-related-evidence":null,"gt-featured":true,"gt-ai-referenced":false,"gt-view-count":56},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Monitoramento Ativo: Acompanhamento Urol\u00f3gico | Rigicon<\/title>\n<meta name=\"description\" content=\"Saiba sobre monitoramento ativo na urologia: acompanhamento regular de condi\u00e7\u00f5es como angiomiolipoma, c\u00e1lculos renais e tumores de baixo risco. EAU.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monitoramento Ativo - Prosthetic Urology Glossary\" \/>\n<meta property=\"og:description\" content=\"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/\",\"name\":\"Monitoramento Ativo: Acompanhamento Urol\u00f3gico | Rigicon\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\"},\"datePublished\":\"2025-07-22T12:24:08+00:00\",\"description\":\"Saiba sobre monitoramento ativo na urologia: acompanhamento regular de condi\u00e7\u00f5es como angiomiolipoma, c\u00e1lculos renais e tumores de baixo risco. EAU.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/glossary-term\\\/monitoramento-ativo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glossary Terms\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/urology-glossary\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Monitoramento Ativo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Monitoramento Ativo: Acompanhamento Urol\u00f3gico | Rigicon","description":"Saiba sobre monitoramento ativo na urologia: acompanhamento regular de condi\u00e7\u00f5es como angiomiolipoma, c\u00e1lculos renais e tumores de baixo risco. EAU.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","og_locale":"pt_BR","og_type":"article","og_title":"Monitoramento Ativo - Prosthetic Urology Glossary","og_description":"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.","og_url":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","url":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/","name":"Monitoramento Ativo: Acompanhamento Urol\u00f3gico | Rigicon","isPartOf":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#website"},"datePublished":"2025-07-22T12:24:08+00:00","description":"Saiba sobre monitoramento ativo na urologia: acompanhamento regular de condi\u00e7\u00f5es como angiomiolipoma, c\u00e1lculos renais e tumores de baixo risco. EAU.","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/pt-br\/glossary-term\/monitoramento-ativo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.rigicon.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Glossary Terms","item":"https:\/\/www.rigicon.com\/pt-br\/urology-glossary\/"},{"@type":"ListItem","position":3,"name":"Monitoramento Ativo"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/pt-br\/#website","url":"https:\/\/www.rigicon.com\/pt-br\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/pt-br\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-term\/12732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-term"}],"about":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/types\/glossary-term"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/media?parent=12732"}],"wp:term":[{"taxonomy":"glossary-category","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-category?post=12732"},{"taxonomy":"glossary-product","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/glossary-product?post=12732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}